Results: 34

Biochemical recurrence after radical prostatectomy: what does it mean?

Int. braz. j. urol; 44 (1), 2018
ABSTRACT Background Radical prostatectomy (RP) has been used as the main primary treatment for prostate cancer (PCa) for many years with excellent oncologic results. However, approximately 20-40% of those patients has failed to RP and presented biochemical recurrence (BCR). Prostatic specific antigen (P...

¿Es el PCA3 costoefectivo en Latinoamérica y el Caribe?

Salud pública Méx; 60 (1), 2018

Clinical perspectives of PSMA PET/MRI for prostate cancer

Clinics; 73 (supl.1), 2018
Prostate cancer imaging has become an important diagnostic modality for tumor evaluation. Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) has been extensively studied, and the results are robust and promising. The advent of the PET/magnetic resonance imaging (MRI) has added m...

Validação experimental da subexpressão de C3a do sistema complemento no plasma de pacientes com carcinoma epidermóide de pênis
Experimental validation of the complement protein C3a down expression in the plasma of patients with squamous cell carcinoma of the penis

O carcinoma epidermóide do pênis (CEP) representa 95% dos tipos de câncer de pênis. No Brasil, a incidência é de 2,7%, mas em algumas áreas do país, a incidência pode chegar a 17% dos casos diagnosticados de câncer por ano. É uma doença agressiva cuja sobrevida em 5 anos pode variar entre 85%...

Does index tumor predominant location influence prognostic factors in radical prostatectomies?

Int. braz. j. urol; 43 (4), 2017
ABSTRACT Purpose To find any influence on prognostic factors of index tumor according to predominant location. Materials and Methods Prostate surgical specimens from 499 patients submitted to radical retropubic prostatectomy were step-sectioned. Each transverse section was subdivided into 2 anterolat...

Low serum testosterone is a predictor of high-grade disease in patients with prostate cancer

Summary Objective: To evaluate the relation between serum total testosterone (TT) and prostate cancer (PCa) grade and the effect of race and demographic characteristics on such association. Method: We analyzed 695 patients undergoing radical prostatectomy (RP), of whom 423 had serum TT collected. Patie...

PSA screening for prostate cancer

Summary Screening of prostate cancer with prostate-specific antigen (PSA) is a highly controversial issue. One part of the controversy is due to the confusion between population screening and early diagnosis, another derives from problems related to the quality of existing screening studies, the results ...

Prostate specific antigen and acinar density: a new dimension, the "Prostatocrit"

Int. braz. j. urol; 43 (2), 2017
ABSTRACT Background Prostate-specific antigen densities have limited success in diagnosing prostate cancer. We emphasise the importance of the peripheral zone when considered with its cellular constituents, the “prostatocrit”. Objective Using zonal volumes and asymmetry of glandular acini...

Predictive value of [-2]propsa (p2psa) and its derivatives for the prostate cancer detection in the 2. 0 to 10. 0ng/mL PSA range

Int. braz. j. urol; 43 (1), 2017
ABSTRACT Introduction To assess predictive value of new tumor markers, precursor of prostate specific antigen (p2PSA) and its derivates-%p2PSA and prostate health index (PHI) in detection of patients with indolent and aggressive prostate cancer (PC) in a subcohort of man whose total PSA ranged from 2 t...

Serum testosterone as a biomarker for second prostatic biopsy in men with negative first biopsy for prostatic cancer and PSA>4ng/mL, or with PIN biopsy result

Int. braz. j. urol; 42 (5), 2016
Abstract Introduction: Data from animal, clinical and prevention studies support the role of androgens in prostate cancer growth, proliferation and progression. Results of serum based epidemiologic studies in humans, however, have been inconclusive. The present study aims to define whether serum testost...